Saturable plasma protein binding model #907
-
Hello everyone, We are working in a PBPK model for a drug which has saturable plasma protein binding kinetic. As strategy, we tried to model free plasma concentrations using unbound fraction (fu) equal to 1 (no real value) and free plasma clearance, and then calculate the total plasma concentrations. However, we have this question: Is fu used for something else besides estimate free plasma concentrations? We read it is used to estimate partition distributions. If the answer is "yes", what strategy do you recommend to model a saturable plasma protein binding process? Alejandra |
Beta Was this translation helpful? Give feedback.
Replies: 4 comments 6 replies
-
I am not sure I can follow what you have done, but to model concentration-dependent fu, you would need to go to MoBi and change the value of fu to a formula. In the past, we have modeled concentration-dependent fu (for a compound primarily bound to albumin) by explicitly modeling albumin as a compound and implementing an albumin binding process in MoBi. hope this helps |
Beta Was this translation helpful? Give feedback.
-
Hi Alejandra, I had a similar a similar case with a drug that had saturable plasma protein binding kinetics. So in order to implement in your model the change of fraction unbound in relation to your drug's concentration you will have to :
You might end up having something like this:
Please feel free to contact me if you need additional information.
Hope that it helps, Please find an example of the 'spatial structure' after doing the process above here: |
Beta Was this translation helpful? Give feedback.
-
Hi Eleni, |
Beta Was this translation helpful? Give feedback.
-
Hi Nina,
Thank you for reaching out.
Please find the answers below :
I noticed you use a function for Fu/Fubase. I was wondering why you would not do the regression immediately for Fu related to total concentration? Is there any reason why you also need to include the Fubase?
It is mandatory to set a reference fraction unbound value in the compound block that will be used when the concentration is 0 as a starting point.
The equation that is developed need to have as dependent variable the Fu corrected with the baseline (Fu/Fubaseline) as this equation is going to be used as a scalar to multiply with the baseline fraction unbound value within the block 'spatial structures' .
So in the spatial structure before including your scalar you have this pre-specified equation for fu :
1 / (1 + (BindingPartner = Albumin ? AlbuminOntgenyFactor : (BindingPartner = Agp ? AgpOntogenyFactor : 1) ) * (1 - fu_ref) / fu_ref) * PlasmaProteinScaleFactor
which for normal adults equalts to fu reference value, i.e. the baseline value set in the compound block in pksim (it was expressed this way to allow the flexibility to scale in children or to pathological states) .
If you develop your scalar equation as fu then it will turn out that the resulting fu, used in the simulation will be
Fu reference * Fu (the fu value yielded for your equation) , on the contrary if you develop and you scalar equation for fu/fu reference then when you implent it you will have Fu reference* Fu/Fu reference =Fu (the value of fraction unbound that you want to use for each concentration).
Could you please explain why you need the Ctotal?
You need to define as a new parameter the Concentration of your drug in the venous blood and then use this parameter as part of your equation that estimates the fu as a function of concentration.
What does this max(Ctotal; 0) function do?
It prevents the ODE solver to yield negative values for Ctotal (can happen for very low concentrations) that will not allow your simulations to run. It is a protection that says that Ctotal is allowed to range from 0 and above.
Is Organism|VenousBlood|Plasma|MOLECULE|Concentration not already the total plasma concentration?
Yes it is but adding it as a parameter allows you to set the dimensions that you want, i..e mg/L or mM or umol/L etc and allows you to introduce protection as described before .
I hope that it helps.
Best regards,
Eleni
…________________________________
Από: nina-nauwelaerts ***@***.***>
Στάλθηκε: Πέμπτη, 17 Ιουνίου 2021 2:03 μμ
Προς: Open-Systems-Pharmacology/Forum ***@***.***>
Κοιν.: ekaratza ***@***.***>; Comment ***@***.***>
Θέμα: Re: [Open-Systems-Pharmacology/Forum] Saturable plasma protein binding model (#907)
Hi Eleni
I noticed you use a function for Fu/Fubase. I was wondering why you would not do the regression immediately for Fu related to total concentration? Is there any reason why you also need to include the Fubase?
Could you please explain why you need the Ctotal? What does this max(Ctotal; 0) function do? Is Organism|VenousBlood|Plasma|MOLECULE|Concentration not already the total plasma concentration?
Kind regards
Nina
—
You are receiving this because you commented.
Reply to this email directly, view it on GitHub<https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgithub.com%2FOpen-Systems-Pharmacology%2FForum%2Fdiscussions%2F907%23discussioncomment-882670&data=04%7C01%7C%7Cafb25f1f982842e104a208d9317f7ed4%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637595245934009032%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=6CQ2WmgdNOIlAjliaLn0y4WorE9nVe%2Bs40kEf9R3U%2BA%3D&reserved=0>, or unsubscribe<https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fgithub.com%2Fnotifications%2Funsubscribe-auth%2FAUKNFRVNWJO5NXGLE5EXHRTTTHI65ANCNFSM457DEQSQ&data=04%7C01%7C%7Cafb25f1f982842e104a208d9317f7ed4%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637595245934019030%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=S7C3whgOLJjx7lJ%2Bli4LYupZ1CFGxaQGna%2BDQgw%2F4B8%3D&reserved=0>.
|
Beta Was this translation helpful? Give feedback.
Hi Alejandra,
I had a similar a similar case with a drug that had saturable plasma protein binding kinetics.
An accurate value of fraction unbound at each time point is very important as it significantly affects clearance and volume of distribution. In PKSim/Mobi suite you can do that very efficiently. The idea is to implement in PKsim/Mobi an equation that relates the fu as a dependent variable to the total concentration of your drug that will be the independent variable .
So in order to implement in your model the change of fraction unbound in relation to your drug's concentration you will have to :